LINC01189

Across TCGA pan-cancer cohorts, LINC01189 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01189’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01189 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01189 is over-expressed in tumor, although a few such as PRAD and ESCA show the opposite, repressed pattern.

KIRC, PRAD, and ESCA are the cancer types where LINC01189 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01189 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.006	.012	4	view →
PRAD	All	All	−0.002	.048	2	view →
ESCA	All	All	−0.013	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC01189–KIRC

Open the KIRC breakdown →